Live Breaking News & Updates on Ematopoietic stem cell transplant

Stay updated with breaking news from Ematopoietic stem cell transplant. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

CareDx Showcases Latest Advances Across AlloSeq Lab Products Portfolio at the 36th European Immunogenetics and Histocompatibility Conference

Posters and Symposium Highlight Utility of AlloSeq for HLA Typing, Organ Transplant Monitoring and Hematopoietic Stem Cell Monitoring

. | April 25, 2023 ....

Bucharest , Bucuresti , Romania , Stockholm , Sweden , Spain , France , United-states , Paris , France-general , California , Brisbane

Theriva Biologics, Inc.: Theriva Biologics Announces Presentation of Data from Cohort 1 of the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients

- Interim blinded safety and pharmacokinetic data to be presented at the 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) -ROCKVILLE, Md., April 13, 2023 (GLOBE NEWSWIRE) ....

Denmark , Copenhagen , Køavn , United-states , American , Theriva-biologics , Erikr-dubberke , Chris-calabrese , Bella-centre-copenhagen , Theriva-biologics-inc , Safety-monitoring-committee , Washington-university-school-of-medicine

Genenta Announces Extension of License Agreement with Ospedale San Raffaele to All Solid Tumor Indications

MILAN, Italy and NEW YORK, April 03, 2023 Genenta Science , a clinical-stage immuno-oncology company developing a cell-based platform harnessing the power of hematopoietic stem cells to provide. | April 3, 2023 ....

Milan , Lombardia , Italy , Italian , Luigi-naldini , Pierluigi-paracchi , Mary-ann-chang , Tiziana-pollio , Exchange-commission , Globenewswire-inc , Ospedale-san-raffaele , Chief-executive-officer

Theriva Biologics, Inc.: Theriva Biologics Announces Presentation of Safety and Pharmacokinetic Data from Cohort 1 of the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients

- Data presented at the 2023 Tandem Meetings: Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR - - Analysis of patients receiving meropenem suggest that SYN-004 is well-tolerated with ....

Florida , United-states , Orlando , American , Dennis-riedl , Theriva-biologics , Stevena-shallcross , Mark-schroeder , Chris-calabrese , Lifesci-advisors , Washington-university-school-of-medicine , Company-annual-report-on-form

Sana Biotechnology Confirms Key Program Timelines and Announces Portfolio Prioritization

Sana is developing a hematopoietic stem cell -targeted fusosome with the ability to deliver gene editing material in vivo to repair genetic abnormalities such as those that cause sickle cell disease. | November 29, 2022 ....

Cambridge , Cambridgeshire , United-kingdom , Steve-harr , Sana-biotechnology-inc , Nasdaq , South-san-francisco , Sana-biotechnology , Quarterly-report , Nc-stock-exchange , News , Nformation